• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.20% Nasdaq Down 0.17%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    19.34 Down 0.41(2.08%) 4:00PM EDT
    |After Hours : 19.34 0.00 (0.00%) 4:00PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:19.75
    Open:19.59
    Bid:17.98 x 100
    Ask:19.85 x 2000
    1y Target Est:38.67
    Beta:3.513
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:19.13 - 19.86
    52wk Range:15.51 - 40.98
    Volume:243,371
    Avg Vol (3m):423,311
    Market Cap:796.90M
    P/E (ttm):N/A
    EPS (ttm):-3.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 2.08%796.90M
    GSKUp 0.40%108.17B
    NVSUp 0.70%252.32B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):28.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.13
    Quarterly EPS Est (Jun-15) :-0.74
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback